Exotrail reports full success of first-ever cubesat mission equipped with Hall-effect electric propulsion technology. This is a major milestone in the company's journey to become a space mobility leader. This success is strengthened by the extremely short development timeframe, with less than a year from design to delivery.

READ MORE

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announces the recruitment of the first patient of its phase 2 GARDEN study to treat COVID-19 _related acute respiratory distress syndrome (ARDS) with glenzocimab.

READ MORE

For the past two years Karista has partnered with the Adolphe Rothschild Foundation Hospital, an international reference in head and neck diseases. This partnership was built on a strong belief: high-potential healthcare companies will emerge from alliances between the worlds of research, innovation and finance.

READ MORE

Catherine Boule, Karista's Managing Partner, shared her valuable thoughts on the trends that we can expect in the digital health industry for 2021 during a Invivox Academy Session on the 11/12/2020. This industry is experiencing an unabated growth revealing a global need affecting everyone at almost the same.

READ MORE

The space sector is undergoing a revolution. Now called NewSpace, it is witnessing the arrival of new agile operators and proponents of disruptive technologies and, like so many other areas of the economy, is in turn being digitalized.

READ MORE

As part of Qorvo, the 35-member 7Hugs Labs team will help create complete UWB solutions – including chips, firmware and software – for a broad ecosystem that is expected to reach billions of devices in the coming years.

READ MORE

We are extremely happy and honored by this opportunity to anchor this partnership with Bioindustry Park Silvano Fumero in Italy, to foster innovation and support innovative founders of startups. This partnership will allow us to connect with ambitious Italian companies in our sectors of interest!

READ MORE

Eyevensys Receives FDA Orphan Drug Designation for EYS611 for Treatment of Retinitis Pigmentosa. EYS611 is a DNA plasmid that encodes for the human transferrin protein, to benefit patients diagnosed with RP, as well as other degenerative retinal diseases.

READ MORE

With the ambition of becoming a European multi-fund management platform, we are proud to announce the appointment of Emmanuel Daugeras as CosmiCapital’s Venture Partner. We are thrilled to have him put his  one-of-a-kind expertise to the service of our fund dedicated to the Newspace.

READ MORE

Under the terms of the deal, the databases developed by Nominet to support adoption of TV White Space internationally – known as WaveDB Connect – and Wave DB Explore, Nominet’s spectrum planning tool – will be acquired and run by RED Technologies.

READ MORE